Royal Bank of Canada’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Royal Bank of Canada's CNMD Position: Q1 2026 in Review
Royal Bank of Canada increased its CONMED (CNMD) stake by 20% in Q1 2026, buying an estimated $154K and bringing the position to 22,619 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #3796.
Royal Bank of Canada first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q4 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Royal Bank of Canada held 22,619 shares of CONMED worth $799K as of Q1 2026.
- Royal Bank of Canada bought 3,790 CONMED shares in Q1 2026, an estimated $154K.
- CONMED made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3796 holding.
- Royal Bank of Canada first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's CONMED position peaked at $27M in Q4 2023.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.